Vanguard Global Advisers’s DexCom DXCM Stock Holding History

Vanguard Global Advisers’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56.1M	Sell	833,079 -9,559	-1%	-$637K	0.03%	385
2026 Q1	$52.9M	Buy	+842,638	New	+$58.7M	0.03%	388

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Global Advisers's DXCM Position: Q2 2026 in Review

Vanguard Global Advisers reduced its DexCom (DXCM) stake by 1.1% in Q2 2026, selling an estimated $637K and leaving 833,079 shares worth $56.1M. The position accounts for 0.03% of the portfolio, ranked #385.

Vanguard Global Advisers first reported a position in DXCM in Q1 2026 and has held it in 2 quarters since. 919 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Vanguard Global Advisers held 833,079 shares of DexCom worth $56.1M as of Q2 2026.
Vanguard Global Advisers sold 9,559 DexCom shares in Q2 2026, an estimated $637K.
DexCom made up 0.03% of Vanguard Global Advisers's portfolio in Q2 2026, its #385 holding.
Vanguard Global Advisers first reported a position in DexCom in Q1 2026 and has held it in 2 quarters since.
919 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.